These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid. Hardin H, Yu XM, Harrison AD, Larrain C, Zhang R, Chen J, Chen H, Lloyd RV. Am J Pathol; 2016 Jun 01; 186(6):1662-73. PubMed ID: 27060227 [Abstract] [Full Text] [Related]
46. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells. Deng J, Yang M, Jiang R, An N, Wang X, Liu B. PLoS One; 2017 Jun 01; 12(1):e0170860. PubMed ID: 28122024 [Abstract] [Full Text] [Related]
47. 1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest. Peng W, Wang K, Zheng R, Derwahl M. Endocr Res; 2016 May 01; 41(2):71-80. PubMed ID: 27030645 [Abstract] [Full Text] [Related]
48. Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells. Paquet-Fifield S, Koh SL, Cheng L, Beyit LM, Shembrey C, Mølck C, Behrenbruch C, Papin M, Gironella M, Guelfi S, Nasr R, Grillet F, Prudhomme M, Bourgaux JF, Castells A, Pascussi JM, Heriot AG, Puisieux A, Davis MJ, Pannequin J, Hill AF, Sloan EK, Hollande F. Cancer Res; 2018 Jun 01; 78(11):2925-2938. PubMed ID: 29510994 [Abstract] [Full Text] [Related]
49. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome. Yun JY, Kim YA, Choe JY, Min H, Lee KS, Jung Y, Oh S, Kim JE. J Clin Pathol; 2014 Feb 01; 67(2):125-33. PubMed ID: 23986551 [Abstract] [Full Text] [Related]
56. A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1. Enomoto K, Sato F, Tamagawa S, Gunduz M, Onoda N, Uchino S, Muragaki Y, Hotomi M. Sci Rep; 2019 Oct 10; 9(1):14616. PubMed ID: 31601917 [Abstract] [Full Text] [Related]
57. Cisplatin induces stemness in ovarian cancer. Wiechert A, Saygin C, Thiagarajan PS, Rao VS, Hale JS, Gupta N, Hitomi M, Nagaraj AB, DiFeo A, Lathia JD, Reizes O. Oncotarget; 2016 May 24; 7(21):30511-22. PubMed ID: 27105520 [Abstract] [Full Text] [Related]
58. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SY. J Clin Endocrinol Metab; 2021 Oct 21; 106(11):e4652-e4665. PubMed ID: 34147031 [Abstract] [Full Text] [Related]
59. Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC). Abdulghani J, Gokare P, Gallant JN, Dicker D, Whitcomb T, Cooper T, Liao J, Derr J, Liu J, Goldenberg D, Finnberg NK, El-Deiry WS. Clin Cancer Res; 2016 Dec 15; 22(24):6192-6203. PubMed ID: 27307592 [Abstract] [Full Text] [Related]